220 related articles for article (PubMed ID: 21786172)
1. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
Teixeira C; Gomes JR; Couesnon T; Gomes P
J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
Thillainayagam M; Anbarasu A; Ramaiah S
J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
Patel PD; Patel MR; Kaushik-Basu N; Talele TT
J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
[TBL] [Abstract][Full Text] [Related]
4. Structural features of falcipain-3 inhibitors: an in silico study.
Wang J; Li F; Li Y; Yang Y; Zhang S; Yang L
Mol Biosyst; 2013 Sep; 9(9):2296-310. PubMed ID: 23765034
[TBL] [Abstract][Full Text] [Related]
5. Profiling the structural determinants of heteroarylnitrile scaffold-based derivatives as falcipain-2 inhibitors by in silico methods.
Wang J; Li Y; Yang Y; Zhang S; Yang L
Curr Med Chem; 2013; 20(15):2032-42. PubMed ID: 23410155
[TBL] [Abstract][Full Text] [Related]
6. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.
Shenai BR; Lee BJ; Alvarez-Hernandez A; Chong PY; Emal CD; Neitz RJ; Roush WR; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Jan; 47(1):154-60. PubMed ID: 12499184
[TBL] [Abstract][Full Text] [Related]
9. Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow.
Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö
J Biomol Struct Dyn; 2016 Oct; 34(10):2084-101. PubMed ID: 26471975
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
Lei B; Du J; Li S; Liu H; Ren Y; Yao X
J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3.
Potshangbam AM; Tanneeru K; Reddy BM; Guruprasad L
Bioorg Med Chem Lett; 2011 Dec; 21(23):7219-23. PubMed ID: 22018459
[TBL] [Abstract][Full Text] [Related]
12. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
14. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.
Rosenthal PJ; Olson JE; Lee GK; Palmer JT; Klaus JL; Rasnick D
Antimicrob Agents Chemother; 1996 Jul; 40(7):1600-3. PubMed ID: 8807047
[TBL] [Abstract][Full Text] [Related]
16. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
17. QM/MM based 3D QSAR models for potent B-Raf inhibitors.
Chung JY; Chung HW; Cho SJ; Hah JM; Cho AE
J Comput Aided Mol Des; 2010 May; 24(5):385-97. PubMed ID: 20358258
[TBL] [Abstract][Full Text] [Related]
18. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
[TBL] [Abstract][Full Text] [Related]
20. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]